Evidence map›Paper›PMID 42630543›Full record

ReviewFrontiers in immunology2026

Pediatric leukemia: origins, pathogenesis, the role of microenvironment and immunological modulation.

Weronika Małkowska, Anna Małkowska, Łukasz Kiraga

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Weronika MałkowskaFaculty of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.
Anna MałkowskaDepartment of Toxicology and Food Science, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.
Łukasz KiragaDivision of Pharmacology and Toxicology, Department of Preclinical Sciences, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukemia remains the most commonly diagnosed pediatric cancer worldwide. Over the last decade, advances in therapy have significantly improved survival rates; however, treatment outcomes are still unsatisfactory for many patients. Further progress requires a comprehensive understanding of disease biology, including the hematopoietic process, mechanisms of leukemia initiation and progression, the genetic mutations involved, and the cell types that constitute the pre-leukemic and leukemic niches and interact with their microenvironment. Particular attention should be paid to the role of inflammation and immune modulation in the development of this childhood malignancy. Hematopoiesis occurs in three waves, and several hematopoietic niches are involved in cell development and maturation. In these locations, primary pre-leukaemic clones arise prenatally, yet only a subset of cases progress to overt leukemia after birth. In most patients, malignant progression is associated with the acquisition of secondary mutations, which may result from inflammation or exposure to specific infectious agents. Microenvironmental factors play a critical role in this process. Cross-talk between niche components and emerging leukaemic cells gradually shapes a microenvironment that favors malignancy. Extensive remodeling of this niche is driven by structural alterations, deregulation of signaling pathways essential for proper cell function and disturbances in the secretion of immunological factors, thereby creating a supportive and protective environment for leukemia progression. A detailed understanding of fetal hematopoiesis in the context of leukemia, and of how immunomodulatory factors and inflammatory mediators influence disease development, is crucial for improving therapeutic efficacy. This review provides an in-depth overview of these phenomena and, in addition to core information on pediatric leukemia, summarizes recent advances in elucidating its origin and pathogenesis, as well as emerging diagnostic and therapeutic approaches.

Indexed as

ImmunomodulationLeukemiaTumor MicroenvironmentAnimalsChildHematopoiesisHumansSignal Transductioncancerhematopoiesisimmunomodulationinflammationmicroenvironmentpediatric leukemia

Identifiers

PMID42630543
PMCPMC13494591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.